[1]
Eid, A.H. Drug repurposing in neurodegenerative and cardiovascular diseases. Curr. Med. Chem., 2021, 28(12), 2303-2304.
[2]
Eid, A.H. Drug repurposing in cancer: Now and beyond. Curr. Med. Chem., 2021, 28(11), 2083-2084.
[3]
Wehbe, Z.; Wehbe, M.; Iratni, R.; Pintus, G.; Zaraket, H.; Yassine, H.M.; Eid, A.H. Repurposing ivermectin for COVID-19: Molecular aspects and therapeutic possibilities. Front. Immunol., 2021, 12, 663586.
[4]
Shakkour, Z.; Habashy, K.J.; Berro, M.; Takkoush, S.; Abdelhady, S.; Koleilat, N.; Eid, A.H.; Zibara, K.; Obeid, M.; Shear, D.; Mondello, S.; Wang, K.K.; Kobeissy, F. Drug repurposing in neurological disorders: implications for neurotherapy in traumatic Brain Injury. Neuroscientist, 2021, 27(6), 620-649.
[5]
El-Hachem, N.; Fardoun, M.M.; Slika, H.; Baydoun, E.; Eid, A.H. Repurposing cilostazol for raynaud’s phenomenon. Curr. Med. Chem., 2021, 28(12), 2409-2417.
[6]
Fasipe, B.; Faria, A.; Laher, I. Potential for novel therapeutic uses of alpha lipoic acid. Curr. Med. Chem., 2023, 30(35), 3942-3954.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
